205 related articles for article (PubMed ID: 27130197)
1. Characterization of cytochrome P450 isoforms involved in sequential two-step bioactivation of diclofenac to reactive p-benzoquinone imines.
den Braver MW; den Braver-Sewradj SP; Vermeulen NP; Commandeur JN
Toxicol Lett; 2016 Jun; 253():46-54. PubMed ID: 27130197
[TBL] [Abstract][Full Text] [Related]
2. Simulation of interindividual differences in inactivation of reactive para-benzoquinone imine metabolites of diclofenac by glutathione S-transferases in human liver cytosol.
den Braver MW; Zhang Y; Venkataraman H; Vermeulen NP; Commandeur JN
Toxicol Lett; 2016 Jul; 255():52-62. PubMed ID: 27183920
[TBL] [Abstract][Full Text] [Related]
3. One-electron oxidation of diclofenac by human cytochrome P450s as a potential bioactivation mechanism for formation of 2'-(glutathion-S-yl)-deschloro-diclofenac.
Boerma JS; Vermeulen NP; Commandeur JN
Chem Biol Interact; 2014 Jan; 207():32-40. PubMed ID: 24246759
[TBL] [Abstract][Full Text] [Related]
4. Effect of human glutathione S-transferases on glutathione-dependent inactivation of cytochrome P450-dependent reactive intermediates of diclofenac.
Dragovic S; Boerma JS; Vermeulen NP; Commandeur JN
Chem Res Toxicol; 2013 Nov; 26(11):1632-41. PubMed ID: 24083800
[TBL] [Abstract][Full Text] [Related]
5. Metabolic activation of diclofenac by human cytochrome P450 3A4: role of 5-hydroxydiclofenac.
Shen S; Marchick MR; Davis MR; Doss GA; Pohl LR
Chem Res Toxicol; 1999 Feb; 12(2):214-22. PubMed ID: 10027801
[TBL] [Abstract][Full Text] [Related]
6. Metabolism related toxicity of diclofenac in yeast as model system.
van Leeuwen JS; Vredenburg G; Dragovic S; Tjong TF; Vos JC; Vermeulen NP
Toxicol Lett; 2011 Feb; 200(3):162-8. PubMed ID: 21111035
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro diclofenac 5-hydroxylation mediated primarily by cytochrome P450 3A enzymes in common marmoset livers genotyped for P450 2C19 variants.
Nakanishi K; Uehara S; Kusama T; Inoue T; Shimura K; Kamiya Y; Murayama N; Shimizu M; Uno Y; Sasaki E; Yamazaki H
Biochem Pharmacol; 2018 Jun; 152():272-278. PubMed ID: 29626440
[TBL] [Abstract][Full Text] [Related]
8. Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes.
Laine JE; Auriola S; Pasanen M; Juvonen RO
Xenobiotica; 2009 Jan; 39(1):11-21. PubMed ID: 19219744
[TBL] [Abstract][Full Text] [Related]
9. Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac.
Tang W; Stearns RA; Wang RW; Chiu SH; Baillie TA
Chem Res Toxicol; 1999 Feb; 12(2):192-9. PubMed ID: 10027798
[TBL] [Abstract][Full Text] [Related]
10. Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinone-imine species in human liver microsomes and recombinant cytochrome P450 3A4.
Kalgutkar AS; Vaz AD; Lame ME; Henne KR; Soglia J; Zhao SX; Abramov YA; Lombardo F; Collin C; Hendsch ZS; Hop CE
Drug Metab Dispos; 2005 Feb; 33(2):243-53. PubMed ID: 15523046
[TBL] [Abstract][Full Text] [Related]
11. The metabolism of diclofenac--enzymology and toxicology perspectives.
Tang W
Curr Drug Metab; 2003 Aug; 4(4):319-29. PubMed ID: 12871048
[TBL] [Abstract][Full Text] [Related]
12. Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways.
Bort R; Macé K; Boobis A; Gómez-Lechón MJ; Pfeifer A; Castell J
Biochem Pharmacol; 1999 Sep; 58(5):787-96. PubMed ID: 10449188
[TBL] [Abstract][Full Text] [Related]
13. Characterization of human cytochrome P450s involved in the bioactivation of clozapine.
Dragovic S; Gunness P; Ingelman-Sundberg M; Vermeulen NP; Commandeur JN
Drug Metab Dispos; 2013 Mar; 41(3):651-8. PubMed ID: 23297297
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometric characterization of protein adducts of multiple P450-dependent reactive intermediates of diclofenac to human glutathione-S-transferase P1-1.
Boerma JS; Dragovic S; Vermeulen NP; Commandeur JN
Chem Res Toxicol; 2012 Nov; 25(11):2532-41. PubMed ID: 22998212
[TBL] [Abstract][Full Text] [Related]
15. Metabolic activation of the nontricyclic antidepressant trazodone to electrophilic quinone-imine and epoxide intermediates in human liver microsomes and recombinant P4503A4.
Kalgutkar AS; Henne KR; Lame ME; Vaz AD; Collin C; Soglia JR; Zhao SX; Hop CE
Chem Biol Interact; 2005 Jun; 155(1-2):10-20. PubMed ID: 15978881
[TBL] [Abstract][Full Text] [Related]
16. Increase in covalent binding of 5-hydroxydiclofenac to hepatic tissues in rats co-treated with lipopolysaccharide and diclofenac: involvement in the onset of diclofenac-induced idiosyncratic hepatotoxicity.
Kishida T; Onozato T; Kanazawa T; Tanaka S; Kuroda J
J Toxicol Sci; 2012; 37(6):1143-56. PubMed ID: 23208430
[TBL] [Abstract][Full Text] [Related]
17. Diclofenac hydroxylation in monkeys: efficiency, regioselectivity, and response to inhibitors.
Tang C; Fang Y; Booth-Genthe C; Kuo Y; Kuduk SD; Rushmore TH; Carr BA
Biochem Pharmacol; 2007 Mar; 73(6):880-90. PubMed ID: 17223083
[TBL] [Abstract][Full Text] [Related]
18. CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs.
Schleiff MA; Crosby S; Blue M; Schleiff BM; Boysen G; Miller GP
Biochem Pharmacol; 2021 Dec; 194():114824. PubMed ID: 34748821
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450-mediated bioactivation of mefenamic acid to quinoneimine intermediates and inactivation by human glutathione S-transferases.
Venkataraman H; den Braver MW; Vermeulen NP; Commandeur JN
Chem Res Toxicol; 2014 Dec; 27(12):2071-81. PubMed ID: 25372302
[TBL] [Abstract][Full Text] [Related]
20. Mechanism-based inactivation of CYP2C11 by diclofenac.
Masubuchi Y; Ose A; Horie T
Drug Metab Dispos; 2001 Sep; 29(9):1190-5. PubMed ID: 11502726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
